About 100 reports

  • 8.6 EDUCATION AND TREATMENT OF PSYCHOLOGICAL FACTORS ACCOMPANYING PLAQUE
  • OUTLINES THE RISK FACTORS AND COMORBIDITIES FOR PLAQUE PSORIASIS.

AND GOODERHAM, M. (2017) ' PSORIASIS, DEPRESSION, AND SUICIDALITY. ', SKIN THERAPY LETTER, ##(##), PP. ##-##.

  • Dermatological Condition
  • United States
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • Comorbidities

HEALTH SURV ENGL 2012, ##:##-##.

  • Dermatological Condition
  • Therapy
  • United States
  • Forecast
  • Pfizer Inc.
  • Comorbidities

Figure ## and Figure ## present the one-year total and one-year diagnosed prevalent cases of AD, respectively.

  • Dermatological Condition
  • Epidemiology
  • Pathology
  • United States
  • Forecast
  • 5.3 GLOBAL AND HISTORICAL TRENDS
  • SYMPTOMATIC REPRESENTATIONS OF ACNE

" People with a history of depression, you wouldn' t give Isotretinoin to them, unless you had to, because Isotretinoin can also cause severe depression. "

  • Dermatological Condition
  • Foamix Ltd.
  • Galderma S.A.
  • Novan, Inc.
  • Valeant Pharmaceuticals International, Inc.
  • 3.2 Global Acne Treatment Market Analysis

This further leads to depression and also development of suicidal tendencies in them.

  • Dermatological Condition
  • World
  • Market Size
  • Actavis plc
  • Allergan plc
  • COMORBIDITIES ASSOCIATED WITH ACNE
  • ACNE

Further, it may increase the chance of tension, depression, and suicidal ideation.

  • Dermatological Condition
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • COMORBIDITIES ASSOCIATED WITH ACNE
  • ACNE

Further, it may increase the chance of tension, depression, and suicidal ideation.

  • Dermatological Condition
  • Allergan plc
  • Foamix Ltd.
  • GlaxoSmithKline plc
  • Novartis AG
  • ORPHAN AND RARE DERMATOLOGY DRUGS MARKET, GLOBAL, PROGNOSIS FOR
  • 2.1 Therapy Area Overview

This can lead to negative selfimage and mental health disorders such as anxiety and depression.

  • Dermatological Condition
  • AbbVie Inc.
  • Amryt Pharma plc
  • Celgene Corporation
  • Fibrocell Science, Inc.
  • Race
  • 3.1 DISEASE BACKGROUND

PLAQUE PSORIASIS PATIENTS ARE OFTEN AFFECTED BY DEPRESSION, HYPERTENSION, ISCHEMIC HEART DISEASE, HYPERLIPIDEMIA, AND PSA. ##. ## RISK FACTORS AND COMORBIDITIES TABLE ## OUTLINES THE RISK FACTORS AND COMORBIDITIES FOR PLAQUE PSORIASIS.

  • Dermatological Condition
  • Pathology
  • United States
  • World
  • Forecast
  • 3.3 GLOBAL AND HISTORICAL TRENDS
  • 3.1 DISEASE BACKGROUND

MEDICAL ELECTRON MICROSCOPY; ##(##): ##-##.

  • Dermatological Condition
  • Germany
  • Japan
  • United States
  • Forecast
  • ALLERGAN

WITHIN THE PHARMACEUTICAL INDUSTRY AS A WHOLE, FINANCIAL DEPRESSION, CONSOLIDATION AND ECONOMIC DOWNTURNS HAVE INFLUENCED THE MARKET.

  • Dermatological Condition
  • World
  • Market Size
  • Galderma S.A.
  • Valeant Pharmaceuticals International, Inc.
  • 2.3.2 Acne Vulgaris
  • 2.7.3 Retinoids

Acne Vulgaris and Depression: A Retrospective Examination.

  • Dermatological Condition
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.
  • Comorbidities Associated with Acne
  • Acne

Further, it may increase the chance of tension, depression, and suicidal ideation.

  • Dermatological Condition
  • Allergan plc
  • Cipla Ltd
  • Novartis AG
  • Sun Pharmaceutical Industries Limited
  • REFERENCES

Marron SE et al., Anxiety, depression, quality of life and patient satisfaction in acne patients treated with oral isotretinoin.

  • Dermatological Condition
  • 4.2 Key Trends & Developments

Epiduo/ Epiduo Forte Revenue Forecast (2017-2022) ##.

  • Dermatological Condition
  • Therapy
  • Forecast
  • Allergan plc
  • Foamix Ltd.
  • 4.4.3 Psoriasis
  • 4.3.3 Psoriasis

Acne Vulgaris and Depression: A Retrospective Examination.

  • Dermatological Condition
  • Market Size
  • Allergan plc
  • Apricus Biosciences, Inc.
  • Pfizer Inc.
  • Acne: An overview
  • Market challenges

You can easily book an appointment with one online.

  • Acne Treatment
  • Dermatological Condition
  • Pharmaceutical
  • Allergan plc
  • Galderma S.A.
  • 2.4 Co-morbidities and Complications
  • 2.1 Therapy Area Introduction

Acne Vulgaris and Depression: A Retrospective Examination.

  • Dermatological Condition
  • Market Size
  • Amgen Inc.
  • Biologics, Inc.
  • Merck & Co., Inc.
  • Executive Summary

It is designed to treat deep to superficial skin depression and volumetric losses.

  • Dermatological Condition
  • Allergan plc
  • Galderma S.A.
  • Pfizer Inc.
  • Valeant Pharmaceuticals International, Inc.

Atopic dermatitis

4385 5000 3900
  • CO-MORBIDITIES OF ATOPIC DERMATITIS RANGE FROM OTHER ATOPIC DISEASES TO NEUROPSYCHIATRIC CONDITIONS

I do not use the very strong ones.

  • Dermatological Condition
  • United States
  • Anacor Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Pfizer Inc.
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H1 2018
  • PIPELINE BY KARUNA PHARMACEUTICALS INC, H1 2018

Increase in M## receptor has been associated with depression.

  • Dermatological Condition
  • Pharmaceutical
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.

It offers products for various therapeutic areas such as Alzheimer' s disease, depression, dystonia, hair loss, liver diseases, Parkinson' s disease, cold, scars, wrinkles and other skin disorders.

  • Clinical Trial
  • Dermatological Condition
  • Prosthesis
  • United States
  • Allergan plc

In this trial, over ## patients will be randomized to receive one of four treatments ## mg ITI-##, ## mg ITI-##, ## mg risperidone (active control) or placebo in a ##:##:##:## ratio.

  • Dermatological Condition
  • Neurological Disorder
  • Neurology
  • Therapy
  • BrainStorm Cell Therapeutics Inc.

In April 2002, Faes Farma filed a patent application (US##/ ##, ##) entitled Polymorph of ##-[##-[##-[##-(##-ethoxyethyl)-##Hbenzimidazole-##-yl]-##-piperidinyl] ethyl]-αα-dimethyl-benzeneacetic acid".

  • Dermatological Condition
  • Therapy
  • Canada
  • United States
  • Product Initiative
  • SEP 13, 2018: XBIOTECH ANNOUNCES COMPLETION AND POSITIVE INTERIM FINDINGS FOR INITIAL COHORT IN BERMEKIMAB PILOT STUDY IN ATOPIC DERMATITIS

The Hospital Anxiety and Depression Scale (HADS) was used to measure patient symptoms of anxiety and depression during the study.

  • Dermatological Condition
  • Monoclonal Antibody
  • United States
  • World
  • Product Initiative

The Hospital Anxiety and Depression Scale (HADS) was used to measure patient symptoms of anxiety and depression during the study.

  • Blood Disease
  • Dermatological Condition
  • United States
  • Company
  • Product Initiative
  • PIPELINE BY ANAVEX LIFE SCIENCES CORP, H2 2017
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY INDICATION, H2 2017

Increase in M## receptor has been associated with depression.

  • Dermatological Condition
  • Pharmaceutical
  • United States
  • Product Initiative
  • Anavex Life Sciences Corp.

The Hospital Anxiety and Depression Scale (HADS) was used to measure patient symptoms of anxiety and depression during the study.

  • Dermatological Condition
  • Therapy
  • United States
  • Product Initiative
  • XBiotech Inc.
  • who participated in a previous dupilumab asthma clinical study. The trial is registered with the EU Clinical Trials Register.

In addition, both trials met key secondary endpoints measuring reduction in itch, improvement in patient-reported anxiety and depression symptoms, and certain quality of life measures.

  • Dermatological Condition
  • Monoclonal Antibody
  • Pharmaceutical
  • Respiratory Disease
  • Regeneron Pharmaceuticals, Inc.
  • APREMILAST - DRUG PROFILE

THE PRIMARY OUTCOME MEASURES OF THE TRIAL WERE CHANGE FROM BASELINE IN THE ##-ITEM HAMILTON DEPRESSION RATING SCALE (HAM-D) TOTAL SCORE.

  • Dermatological Condition
  • Therapy
  • United States
  • Product Initiative
  • Cara Therapeutics, Inc.